Esther Jiménez-rekin lankidetzan egindako argitalpenak (21)

2024

  1. Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging

    European Neuropsychopharmacology, Vol. 85, pp. 23-31

  2. Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms

    Molecular Psychiatry, Vol. 29, Núm. 7, pp. 2050-2058

2022

  1. Corrigendum to “Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population” [J. Affect. Disord. 249 (2019) 199–207 (Apr 15), (2019) 249(199-207) (S0165032718329604), (10.1016/j.jad.2019.02.037))

    Journal of Affective Disorders

2021

  1. Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder

    Revista de Psiquiatria y Salud Mental

2020

  1. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

2019

  1. Association of childhood trauma and genetic variability of CRH-BP and FKBP5 genes with suicidal behavior in bipolar patients

    Journal of Affective Disorders, Vol. 255, pp. 15-22

  2. Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population

    Journal of Affective Disorders, Vol. 249, pp. 199-207

2018

  1. Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder

    Journal of Affective Disorders, Vol. 232, pp. 229-236

  2. Characterizing decision-making and reward processing in bipolar disorder: A cluster analysis

    European Neuropsychopharmacology, Vol. 28, Núm. 7, pp. 863-874

  3. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154

2017

  1. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

    European Neuropsychopharmacology, Vol. 27, Núm. 4, pp. 350-359

  2. Impact of childhood trauma on cognitive profile in bipolar disorder

    Bipolar Disorders, Vol. 19, Núm. 5, pp. 363-374

2016

  1. Clinical features, impulsivity, temperament and functioning and their role in suicidality in patients with bipolar disorder

    Acta Psychiatrica Scandinavica, Vol. 133, Núm. 4, pp. 266-276

  2. Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life

    Acta Psychiatrica Scandinavica, Vol. 133, Núm. 5, pp. 386-398

  3. Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory

    Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301

  4. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome

    British Journal of Psychiatry, Vol. 208, Núm. 1, pp. 87-93

  5. Validación de la versión en español de la Columbia-Suicide Severity Rating Scale (Escala Columbia para Evaluar el Riesgo de Suicidio)

    Revista de Psiquiatria y Salud Mental, Vol. 9, Núm. 3, pp. 134-142

2015

  1. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association with IMPA2, INPP1, and GSK3B Genes

    Journal of Clinical Psychopharmacology, Vol. 35, Núm. 5, pp. 600-604

  2. Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms

    European Neuropsychopharmacology, Vol. 25, Núm. 2, pp. 257-264

2014

  1. Association between GSK3β gene and increased impulsivity in bipolar disorder

    European Neuropsychopharmacology, Vol. 24, Núm. 4, pp. 510-518